Related Experiment Videos
Weight gain and cardiovascular risk after organ transplantation
1Department of Medicine, University of Illinois at Chicago, 60612, USA. baum@uic.edu
Insights
Organ transplant recipients face increased cardiovascular disease risk due to factors like hypertension and diabetes, often worsened by immunosuppressive drugs. Managing these risks is crucial for long-term patient survival and well-being.
Area of Science:
- Nephrology
- Cardiology
- Immunology
Background:
- Organ transplantation is a common treatment for organ failure, leading to improved long-term survival.
- Cardiovascular disease (CVD) is now the leading cause of death in renal transplant recipients and a major complication in other organ recipients.
- Risk factors for CVD include hypertension, posttransplant diabetes, hyperlipidemia, and obesity, often exacerbated by immunosuppressive medications.
Purpose of the Study:
- To review the incidence and implications of cardiovascular disease risk factors in organ transplant recipients.
- To discuss strategies for the clinical management of these risk factors.
- To identify future research directions in this field.
Main Methods:
- Literature review of studies on cardiovascular disease risk factors in organ transplant recipients.
- Analysis of the impact of immunosuppressive medications on cardiovascular health.
- Examination of weight gain and obesity as contributing factors.
Main Results:
- Cardiovascular disease is a primary concern in long-term organ transplant survivors.
- Immunosuppressive drugs contribute to hypertension, diabetes, hyperlipidemia, and obesity.
- Posttransplant weight gain affects about 50% of patients, synergizing with medication effects to increase CVD risk.
Conclusions:
- Cardiovascular disease risk factors are prevalent and significant in organ transplant recipients.
- Effective clinical management strategies are needed to mitigate these risks.
- Further research is essential to address the complex interplay of factors contributing to CVD post-transplantation.
Abstract:
Organ transplantation has become a common and effective approach to the management of patients with organ failure. The improvement in long-term survival has resulted in the emergence of cardiovascular disease as the primary cause of death in renal transplant patients and a significant complication in other organ recipients. A number of factors explain this trend, including a high incidence of hypertension, posttransplant diabetes, hyperlipidemia, and obesity-risk factors that are mediated by direct effects of immunosuppressive medications. Weight gain posttransplant affects approximately 50% of patients and represents a significant problem because of the potential synergism between obesity and immunosuppressive medication-induced effects on cardiovascular disease risk factor development. This review discusses the incidence and implications of cardiovascular disease risk factors in organ transplant recipients, strategies for clinical management, and future research directions.